Please assess the completion status of the following clinical trial:

Trial Title: Genotropin Treatment In Very Young Children Born Small For Gestational Age

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Caucasian male or female subjects aged between 19-29 months at Screening Visit 1.~Born SGA (birth length and/or weight \<-2 SD for gestational age, using country-specific standards).~Height below -2.5 SD at screening (19-29 months of age). At least one measurement of length between 12 and 18 months of age. Normal karyotype in girls to exclude Turners syndrome.~Exclusion Criteria:~Severe Intra-Uterine Growth Retardation (IUGR) (birth length below - 4 SD for gestational age), if associated with dysmorphic features.~Severe prematurity (Gestational Age (GA) \<32 weeks of gestation). Ongoing catch-up growth (defined as growth velocity SDS at inclusion \>0) based on at least 4 months measurement interval).~Severe familial short stature defined as: Father's height below 155 cm or mother's height below 145 cm.~Defined neurological defects and/or severe neurodevelopmental delay.

- Gender: ALL
- Minimum Age: 19 Months
- Maximum Age: 29 Months
- Healthy Volunteers: f

Study Arms:
- Active (Type: EXPERIMENTAL): The active treatment arm
- Control (Type: EXPERIMENTAL): Control

Based on this trial design, predict the completion outcome and termination type (if applicable).